Sunday, 29 May 2022 18:32

: A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?

Written by MarketWatch
Rate this item
(0 votes)
Pfizer’s promising ulcerative colitis treatment could generate $1.9 billion in sales by 2030. Lilly’s got a drug in development, too.

Read more from our friends at MarketWatch

Read 115 times